Form 8-K - Current report:
SEC Accession No. 0001171843-23-003757
Filing Date
2023-06-05
Accepted
2023-06-05 07:40:13
Documents
18
Period of Report
2023-06-05
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_060223.htm   iXBRL 8-K 18494
2 EXHIBIT 3.1 exh_31.htm EX-3.1 1775
3 PRESS RELEASE exh_991.htm EX-99.1 8025
4 exh31_01.jpg GRAPHIC 49773
5 exh31_02.jpg GRAPHIC 49895
6 exh31_03.jpg GRAPHIC 51799
  Complete submission text file 0001171843-23-003757.txt   442642

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3069
8 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25640
9 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
10 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
12 EXTRACTED XBRL INSTANCE DOCUMENT f8k_060223_htm.xml XML 3120
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 23991227
SIC: 2836 Biological Products, (No Diagnostic Substances)